Clinical Trial Update: A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 study evaluating the efficacy and safety of ALN-AGT01 in adults with mild to moderate hypertension; results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• ALN-AGT01

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2024-12-27